These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33145060)
1. Association between blood eosinophils with exacerbation and patient-reported outcomes in chronic obstructive pulmonary disease patients in an endemic area for parasitic infections: a prospective study. Juthong S; Kaenmuang P J Thorac Dis; 2020 Sep; 12(9):4868-4876. PubMed ID: 33145060 [TBL] [Abstract][Full Text] [Related]
2. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314 [TBL] [Abstract][Full Text] [Related]
4. Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials. Singh D; Wedzicha JA; Siddiqui S; de la Hoz A; Xue W; Magnussen H; Miravitlles M; Chalmers JD; Calverley PMA Respir Res; 2020 Sep; 21(1):240. PubMed ID: 32943047 [TBL] [Abstract][Full Text] [Related]
5. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis. Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722 [TBL] [Abstract][Full Text] [Related]
6. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881 [TBL] [Abstract][Full Text] [Related]
7. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028 [TBL] [Abstract][Full Text] [Related]
8. Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO. Pavord ID; Chapman KR; Bafadhel M; Sciurba FC; Bradford ES; Schweiker Harris S; Mayer B; Rubin DB; Yancey SW; Paggiaro P Int J Chron Obstruct Pulmon Dis; 2021; 16():1755-1770. PubMed ID: 34163157 [TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcome Related to Blood Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Patients. Albanna A; Almuyidi FM; Beitar NF; Alshumrani AS; Al Nufaiei ZF; Khayat R; Althaqafy M; Abdulmannan HI Cureus; 2022 Aug; 14(8):e27998. PubMed ID: 36134112 [TBL] [Abstract][Full Text] [Related]
10. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality. Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000 [TBL] [Abstract][Full Text] [Related]
11. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma. Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949 [TBL] [Abstract][Full Text] [Related]
12. Stability in eosinophil categorisation during subsequent severe exacerbations of COPD. Citgez E; van der Palen J; van der Valk P; Kerstjens HAM; Brusse-Keizer M BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376399 [TBL] [Abstract][Full Text] [Related]
13. Anti-IL-5 therapies for chronic obstructive pulmonary disease. Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032 [TBL] [Abstract][Full Text] [Related]
14. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada. Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220 [TBL] [Abstract][Full Text] [Related]
15. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization. Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252 [TBL] [Abstract][Full Text] [Related]
16. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis. Jabarkhil A; Moberg M; Janner J; Petersen MN; Jensen CB; Henrik Äangquist L; Vestbo J; Jess T; Porsbjerg C Eur Clin Respir J; 2020; 7(1):1757274. PubMed ID: 32489532 [No Abstract] [Full Text] [Related]
17. Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study. Kaenmuang P; Navasakulpong A; Geater SL; Densrisereekul S; Juthong S Chronic Obstr Pulm Dis; 2024 Jul; 11(4):350-358. PubMed ID: 38575373 [TBL] [Abstract][Full Text] [Related]
18. Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis. Chan MC; Yeung YC; Yu ELM; Yu WC Int J Chron Obstruct Pulmon Dis; 2020; 15():2869-2877. PubMed ID: 33204083 [TBL] [Abstract][Full Text] [Related]
19. Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Hegewald MJ; Horne BD; Trudo F; Kreindler JL; Chung Y; Rea S; Blagev DP Int J Chron Obstruct Pulmon Dis; 2020; 15():2629-2641. PubMed ID: 33122901 [TBL] [Abstract][Full Text] [Related]
20. Burden of disease associated with a COPD eosinophilic phenotype. Ortega H; Llanos JP; Lafeuille MH; Germain G; Duh MS; Bell CF; Sama SR; Hahn B Int J Chron Obstruct Pulmon Dis; 2018; 13():2425-2433. PubMed ID: 30147308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]